HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Eplivanserin Fumarate

HCID 135456189
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
130580-02-8
Standard SMILES
CN(C)CCO/N=C(/C=C/c1ccc(O)cc1)c1ccccc1F.CN(C)CCO/N=C(/C=C/c1ccc(O)cc1)c1ccccc1F.O=C(O)/C=C/C(=O)O
InChIKey
RNLKLYQQDLHHBH-ABDBJYMXSA-N
Molecular formula
C42H46F2N4O8
Average molar mass
772.8 g/mol
Monoisotopic mass
772.32837076

Overview

potent & selective 5-hydroxytryptamine receptor antagonist; structure given in first source

Names & identifiers

Preferred name
Eplivanserin Fumarate
IUPAC
(E)-but-2-enedioic acid;bis(4-[(E,3Z)-3-[2-(dimethylamino)ethoxyimino]-3-(2-fluorophenyl)prop-1-enyl]phenol)
English name
EPLIVANSERIN FUMARATE
Molecular formula
C23H25FN2O6
Molecular weight
444.46

Names & synonyms

Eplivanserin hemifumarateEplivanserin fumarate130580-02-8BT8UYC46KAEplivanserin fumarate [USAN]SR46349BSR 46349BUNII-BT8UYC46KA(1Z,2E)-1-(2-FLUOROPHENYL)-3-(4-HYDROXYPHENYL)PROP-2-EN-1-ONE O-(2-(DIMETHYLAMINO)ETHYL)OXIME (2E)-BUT-2-ENEDIOATE (2:1) (SALT)RefChem:137312(4-((1E,3Z)-3-((2-(DIMETHYLAMINO)ETHOXY)IMINO)-3-(2-FLUOROPHENYL)PROP-1-ENYL)PHENOL)(2E)-2-BUTENEDIOATE (2:1)2-PROPEN-1-ONE, 1-(2-FLUOROPHENYL)-3-(4-HYDROXYPHENYL)-, O-(2-(DIMETHYLAMINO)ETHYL)OXIME, (1Z,2E)-, (2E)-2-BUTENEDIOATE (2:1)
Show more names
SR-46349 FumarateSR-46349 hemifumarateSR-46349 hemifumarate saltEplivanserin hemifumarate saltSR-46349 hemifumarate salt >=98% (HPLC)TRANS-2''-FLUORO-4-HYDROXYCHALCONE O-[(Z)-2-(DIMETHYLAMINO)ETHYL]OXIME--FUMARIC ACID (2:1)4-((3Z)-3-(2-Dimethylaminoethyl)oxyimino-3-(2-fluorophenyl)propen-1-yl)phenol hemifumarate salt
SR-46349B(E)-but-2-enedioic acid;4-[(E,3Z)-3-[2-(dimethylamino)ethoxyimino]-3-(2-fluorophenyl)prop-1-enyl]phenolSR 46349DTXSID201033898EplivanserinhemifumarateSR-46349 hemifumarat4-((3Z)-3-(2-Dimethylaminoethyl)oxyimino-3-(2-fluorophenyl)propen-1-yl)phenol hemifumarate2-Propen-1-one, 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)-, O-(2-(dimethylamino)ethyl)oxime, (Z,E)-, (E)-2-butenedioate (2:1) (salt)

Properties

Computed structural properties

Topological polar surface area
165 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
14
Rotatable bonds
16
Heavy atoms
56
Formal charge
0
Complexity
537

Physicochemical properties

storage temp.
2 · 2-8°C
solubility
10 mg/mL · DMSO: ≥10mg/mL
form
powder
color
white to off-white
InChIKey
RNLKLYQQDLHHBH-ABDBJYMXSA-N
SMILES
OC(=O)\C=C\C(O)=O.CN(C)CCO\N=C(\C=C\c1ccc(O)cc1)c2ccccc2F.CN(C)CCO\N=C(\C=C\c3ccc(O)cc3)c4ccccc4F
FDA UNII
8 UYC46KA · BT8UYC46KA
UNSPSC Code
12352200 · 12352200
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07,GHS09
Signal word
Warning
Hazard statements
302 · H302-H410
Precautionary statements
273 · P273-P501
Hazard Codes
Xn,N
Risk Statements
22 · 22-50
Safety Statements
61 · 61
RIDADR
3077 · UN 3077 9 / PGIII

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P273, P301+P317, P330, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety data

wgk
2
ridadr
UN 3077 9 / PGIII
risk_code
22-50
Signal word
Warning
Symbol(GHS)
GHS07,GHS09
hazard_code
Xn,N
safety_code
61
Storage Class
11 - Combustible Solids
Hazard statements
H302-H410
Hazard Classifications
Acute Tox. 4 OralAquatic Acute 1Aquatic Chronic 1
Precautionary statements
P273-P501

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 3 items

Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.

Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.

Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS.

Applications

UsesEplivanserin Hemifumarate is a 5-HT2A antagonist.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
130580-02-8
PubChem CID
135456189
DTXSID
DTXSID201033898
ChEMBL
CHEMBL2103845
UNII
BT8UYC46KA
EC Number
681-305-1
WGK Germany
2 · 2
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
4 OralAquatic · Acute Tox. 4 OralAquatic Acute 1Aquatic Chronic 1